Foscarnet Kabi (Foscarnet Sodium Hexahydrate)

Foscarnet Sodium Hexahydrate is an antiviral medication used for intravenous administration. It is primarily indicated for the treatment of certain viral infections, including cytomegalovirus (CMV) retinitis in patients with AIDS. This medication is manufactured by Fresenius Kabi France S.A.S.

Foscarnet Sodium Hexahydrate is used to treat viral infections, particularly CMV retinitis in patients with AIDS. It works by inhibiting the replication of the virus, helping to manage the infection. This medication is administered intravenously and is prescribed by healthcare professionals for specific viral conditions.

Common effects of Foscarnet Sodium Hexahydrate may include kidney problems, changes in electrolyte levels, and nausea. Some patients may also experience fever, diarrhea, or changes in blood cell counts. It is important to monitor for these effects and consult a healthcare provider if they occur.

Foscarnet Sodium Hexahydrate should be used with caution in patients with kidney problems. Regular monitoring of kidney function and electrolyte levels is recommended. Patients should stay hydrated and follow the advice of their healthcare provider to minimize potential risks.

Foscarnet Sodium Hexahydrate may interact with other medications, including those that affect kidney function or electrolyte levels. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy of this medication.